
Lorem Ipsum Pharma Private Limited
About Lorem Ipsum Pharma Private Limited
Data last updated:
Lorem Ipsum Pharma Private Limited is a private limited company based in Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 27 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2011PTC226788.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka and Ashu Vohra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 478 Block – Ag Shalimar Bagh, Delhi, India – 110088.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lorem Ipsum Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address478 Block – Ag Shalimar Bagh, Delhi, India – 110088
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Lorem Ipsum Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lorem Ipsum Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
Financials of Lorem Ipsum Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Lorem Ipsum Pharma Private Limited, buy the company report.
Board of directors of Lorem Ipsum Pharma Private Limited
Lorem Ipsum Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka | Director | 27 Oct 2011 | 15 Years 0 Months | Current |
| Ashu Vohra | Director | 27 Oct 2011 | 15 Years 0 Months | Current |
Auditor
Lorem Ipsum Pharma Private Limited is audited by ADISH JAIN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ADISH JAIN | FY 2017 | 515436 |
Shareholding
The shareholding of Lorem Ipsum Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Lorem Ipsum Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lorem Ipsum Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lorem Ipsum Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lorem Ipsum Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lorem Ipsum Pharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Ashu Vohra was appointed as Director on 27 Oct 2011.
Frequently asked questions
Lorem Ipsum Pharma is an active private limited company based in Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 27 October 2011 (15+ years old) and is registered under CIN U85100DL2011PTC226788.
Lorem Ipsum Pharma has 2 current directors:
- Priyanka - Director
- Ashu Vohra - Director
The latest financial statements of Lorem Ipsum Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Lorem Ipsum Pharma is U85100DL2011PTC226788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lorem Ipsum Pharma was incorporated on 27 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Ashu Vohra was appointed as Director on 27 Oct 2011. Priyanka was appointed as Director on 27 Oct 2011.
The registered office of Lorem Ipsum Pharma is at 478 Block – Ag Shalimar Bagh, Delhi, India – 110088.
Lorem Ipsum Pharma operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Lorem Ipsum Pharma is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.
Lorem Ipsum Pharma can be reached at its registered office: 478 Block – Ag Shalimar Bagh, Delhi, India – 110088.

